12:07:21 100 0.25 + PAC bb ex
12:05:57 40000 0.23 - NASD ADF tt
12:05:54 5000 0.23 - AMEX
12:05:54 59800 0.2499 - NASD ADF tt
12:05:54 100 0.2499 - NASD ADF bb tc
12:05:54 800 0.2499 - CINC bb ex
12:05:54 200 0.2499 - NASD ADF bb tc
12:05:54 300 0.2499 - NASD ADF tc
12:05:54 300 0.2499 - NASD ADF bb tc
12:05:54 1500 0.2499 - NASD ADF bb tc
12:05:54 1400 0.2499 - NASD ADF bb tc
12:05:54 1800 0.2499 - NASD ADF tc
12:05:51 4400 0.2499 - NASD ADF tc
12:05:51 600 0.2499 - NASD ADF bb tc
11:55:27 100 0.25 + OTC bb ex
11:55:27 100 0.25 + OTC bb ex
11:52:39 1000 0.25 + NASD ADF tt
11:49:51 200 0.2499 - NASD ADF tc
11:49:36 300 0.2499 - NASD ADF tc
11:49:30 708 0.2499 - NASD ADF tt
11:48:09 200 0.25 + NASD ADF tt
11:46:36 4000 0.2499 - NASD ADF tt
11:43:57 1000 0.25 + NASD ADF tt
11:43:54 1000 0.25 + NASD ADF tt
11:36:39 6000 0.2497 - NASD ADF tt
11:36:39 20000 0.2497 - NASD ADF tt
11:36:33 3500 0.2498 - NASD ADF tc
11:36:33 5000 0.2498 - NASD ADF tc
11:36:30 5000 0.2498 - NASD ADF tc
11:36:30 4300 0.2499 - NASD ADF tc
11:36:30 5000 0.2499 - NASD ADF tc
11:35:27 1000 0.25 + NASD ADF tt
11:32:21 10000 0.2498 - NASD ADF tt
11:32:18 1072 0.2499 - NASD ADF tc
11:32:18 2000 0.2499 - NASD ADF tc
11:32:18 2000 0.2499 - NASD ADF tc
11:32:18 2000 0.2499 - NASD ADF tc
11:32:18 100 0.25 + NASD ADF tt
11:32:18 2000 0.2499 - NASD ADF tc
11:32:18 2000 0.2499 - NASD ADF tc
11:32:18 2000 0.25 + NASD ADF tt
11:06:36 760 0.25 + NASD ADF tt
11:06:36 100 0.25 + OTC bb ex
11:06:36 600 0.25 + OTC bb ex
11:05:48 1300 0.2499 + NASD ADF tc
11:05:06 5000 0.2499 + NASD ADF tt
11:04:21 200 0.2499 + NASD ADF tc
10:44:00 708 0.2332 - NASD ADF tt
10:26:48 480 0.2456 + NASD ADF tt
10:22:12 3000 0.23 - AMEX
10:22:12 1400 0.23 - NASD ADF tt
10:19:48 1600 0.234 + NASD ADF tt
10:11:33 17500 0.23 - NASD ADF tt
10:07:33 2500 0.24 - NASD ADF tt
09:57:51 2500 0.25 + NASD ADF tt
09:57:12 4200 0.23 + AMEX
09:56:45 5000 0.22 + NASD ADF tt
09:54:30 1075 0.22 + OTC bb ex
09:54:27 1300 0.22 + NASD ADF tc
09:54:27 1300 0.22 + NASD ADF tc
09:54:27 1300 0.22 + NASD ADF tc
09:47:57 100 0.22 + OTC bb ex
09:44:30 15000 0.21 - NASD ADF tt
09:37:27 500 0.21 - NASD ADF tt
09:30:15 10000 0.21 - AMEX op
09:30:00 175 0.22 OTC op xt
Recent HCM News
- HUTCHMED Announces NDA Acceptance in China for Tazemetostat for the Treatment of Relapsed or Refractory Follicular Lymphoma with Priority Review Status • GlobeNewswire Inc. • 07/04/2024 12:00:00 AM
- HUTCHMED to Announce 2024 Half-Year Financial Results • GlobeNewswire Inc. • 06/26/2024 08:30:00 AM
- Save the Date: HUTCHMED to Present R&D Updates on July 9, 2024 • GlobeNewswire Inc. • 06/24/2024 09:30:00 AM
- HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda • GlobeNewswire Inc. • 06/21/2024 08:00:00 PM
- HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology • GlobeNewswire Inc. • 06/17/2024 12:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/07/2024 10:25:35 AM
- HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological Malignancies in China • GlobeNewswire Inc. • 06/07/2024 12:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/03/2024 10:13:17 AM
- HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine • GlobeNewswire Inc. • 06/03/2024 12:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/31/2024 10:12:22 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/24/2024 10:06:58 AM
- HUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting • GlobeNewswire Inc. • 05/24/2024 12:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/17/2024 02:02:55 PM
- HUTCHMED announces retirement of Chairman, appointment of new Chairman and change of members of board committees • GlobeNewswire Inc. • 05/17/2024 02:00:00 PM
- HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress • GlobeNewswire Inc. • 05/17/2024 12:00:00 AM
- HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma in Collaboration with Hengrui • GlobeNewswire Inc. • 05/14/2024 12:00:00 AM
- HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China • GlobeNewswire Inc. • 05/14/2024 12:00:00 AM
- HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee • GlobeNewswire Inc. • 05/08/2024 08:30:00 AM
- HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda • GlobeNewswire Inc. • 04/26/2024 12:30:00 PM
- HUTCHMED Highlights Data to be Presented at AACR Congress 2024 • GlobeNewswire Inc. • 04/05/2024 08:30:00 AM
- HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status • GlobeNewswire Inc. • 04/02/2024 04:30:00 AM
- HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC • GlobeNewswire Inc. • 03/28/2024 12:00:00 AM
- HUTCHMED Initiates Registration Stage of the ESLIM-02 Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China • GlobeNewswire Inc. • 03/22/2024 12:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2024 11:04:49 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/28/2024 11:47:15 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM